SCHEMBL430692

SCHEMBL430692

CCC(C)(C1CCC(N)CC1)C1CCC(N)CC1

nearest known ligand 0.32

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
GNAI3 P08754 1/20 0.32
GNAO1 P09471 1/20 0.32
GNAI1 P63096 1/20 0.32
SPHK1 Q9NYA1 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12852025 0.80 KDM4E (0.35)
SCHEMBL14107832 0.80
SCHEMBL9051339 0.80 KDM4E (0.35)
SCHEMBL1764771 0.80 KDM4E (0.35)
Hydrochloric Acid SCHEMBL2994325 0.78 KDM4E (0.34) GNAI3GNAO1GNAI1
SCHEMBL15314465 0.78
Hydrochloric Acid SCHEMBL2994327 0.78 KDM4E (0.34) GNAI3GNAO1GNAI1
SCHEMBL11016040 0.77
SCHEMBL22421512 0.76
SCHEMBL9815775 0.75 SHBG (0.39)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 130 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080226845-A1 Polyamic acid-based composition and liquid crystal orienting film DAILY POLYMER CO., LTD. 2008-09-18 US claimed
US-12559586-B2 Compositions containing uretdione groups crosslinking at low temperatures COVESTRO DEUTSCHLAND AG (DE) 2026-02-24 US disclosed
EP-3938416-B1 POLYURETHANE COATING COMPOSITIONS AND THEIR USE AS GEL COATS COVESTRO LLC (US) 2025-09-10 EP disclosed
EP-4277941-B1 COMPOSITIONS CONTAINING URETDIONE GROUPS COVESTRO DEUTSCHLAND AG (DE) 2025-01-01 EP disclosed
EP-4157912-B1 COMPOSITIONS CONTAINING URETDIONE GROUPS CROSSLINKING AT LOW TEMPERATURES COVESTRO DEUTSCHLAND AG (DE) 2024-05-22 EP disclosed
EP-3959251-B1 LATENT REACTIVE ADHESIVE PREPARATIONS COVESTRO DEUTSCHLAND AG (DE) 2024-03-27 EP disclosed
EP-3129353-B1 METHOD FOR MANUFACTURING XYLYLENE DIISOCYANATES IN THE GASEOUS PHASE COVESTRO DEUTSCHLAND AG (DE) 2024-02-28 EP disclosed
EP-4277941-A1 COMPOSITIONS COMPRISING URETDIONES Covestro Deutschland AG (DE) 2023-11-22 EP disclosed
EP-3997183-B1 METHOD FOR THE PRODUCTION OF ISOCYANURATES FROM URETDIONES COVESTRO INTELLECTUAL PROPERTY GMBH & CO KG (DE) 2023-10-04 EP disclosed
US-20230192941-A1 COMPOSITIONS CONTAINING URETDIONE GROUPS CROSSLINKING AT LOW TEMPERATURES COVESTRO DEUTSCHLAND AG (DE) 2023-06-22 US disclosed
US-5663272-A STORAGE STABLE LIQUID MADE FROM DIPHENYLMETHANE DIISOCYANATE AND MONOISOCYANATES BAYER CORPORATION (US) 1997-09-02 US disclosed
US-5607998-A Process for the repair of plastic parts using non-sagging, sandable polyurethane compositions BAYER CORPORATION (US) 1997-03-04 US disclosed
US-5502147-A POLYURETHANES BAYER CORPORATION (US) 1996-03-26 US disclosed
EP-0659792-A2 Aliphatic polyurethane RIM elastomers Bayer Corporation (US) 1995-06-28 EP disclosed
US-4764543-A Microcellular foamed or reaction injection molded polyurethane/polyureas employing amine terminated polymers and diamine chain extenders THE DOW CHEMICAL COMPANY (US) 1988-08-16 US disclosed
EP-0099516-A1 Process for the preparation of bis(aminocyclohexyl)dialkyl methanes BASF Aktiengesellschaft (DE) 1984-02-01 EP disclosed
EP-0003954-B1 REACTIVE POLYOL COMPOSITIONS AND HIGH RESILIENCY POLYURETHANE FOAMS OBTAINED BY USING THESE COMPOSITIONS BASF WYANDOTTE CORPORATION (US) 1983-08-24 EP disclosed
US-4384052-A Polyurethanes produced from an adduct of an organic polyisocyanate and certain amines BASF WYANDOTTE CORPORATION (US) 1983-05-17 US disclosed
US-4210728-A Preparation of high resiliency polyurethane foams BASF WYANDOTTE CORPORATION (US) 1980-07-01 US disclosed
EP-0003954-A1 Reactive polyol compositions and high resiliency polyurethane foams obtained by using these compositions BASF WYANDOTTE CORPORATION (US) 1979-09-19 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12559586-B2 Compositions containing uretdione groups crosslinking at low temperatures URB2, UQCRB, UQCRC2 GNAI3 3668/4885GNAO1 1347/4885GNAI1 3365/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.